Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHX02 for acute bronchitis (phase 3, randomized, double-blind, active comparator-controlled)
KCT0010910Phase 3Completed
- Sponsor
- Daejeon Korean Medicine Hospital of Daejeon University
- Start
- Apr 2023
- Countries
- 1
01
Overview
A Phase 3 trial of GHX02 in acute bronchitis, sponsored by Daejeon Korean Medicine Hospital of Daejeon University. Started Apr 2023; status: completed.
02
Drugs
GHX02
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on KCT0010910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010910.